Kapil Dhingra

3.7k total citations · 1 hit paper
63 papers, 2.9k citations indexed

About

Kapil Dhingra is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Kapil Dhingra has authored 63 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Kapil Dhingra's work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (10 papers) and HER2/EGFR in Cancer Research (6 papers). Kapil Dhingra is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (10 papers) and HER2/EGFR in Cancer Research (6 papers). Kapil Dhingra collaborates with scholars based in United States, United Kingdom and India. Kapil Dhingra's co-authors include Gabriel N. Hortobágyi, Aman U. Buzdar, Nour Sneige, S. Eva Singletary, Kelly K. Hunt, Lisa A. Newman, Henry M. Kuerer, Merrick I. Ross, Thomas A. Buchholz and Richard L. Theriault and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kapil Dhingra

62 papers receiving 2.8k citations

Hit Papers

Clinical Course of Breast Cancer Patients With Complete P... 1999 2026 2008 2017 1999 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
    1999 1.1k citations Kapil Dhingra, Richard L. Theriault et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kapil Dhingra United States 24 1.4k 1.2k 763 687 436 63 2.9k
M. Bontenbal Netherlands 31 1.2k 0.8× 2.1k 1.8× 575 0.8× 299 0.4× 667 1.5× 66 3.4k
Vincent Caggiano United States 23 1.8k 1.3× 2.5k 2.2× 736 1.0× 603 0.9× 658 1.5× 55 3.8k
D C Tormey United States 32 1.1k 0.8× 2.1k 1.8× 561 0.7× 578 0.8× 644 1.5× 55 3.6k
Kathleen M. Darcy United States 39 961 0.7× 1.8k 1.6× 2.1k 2.7× 677 1.0× 446 1.0× 174 5.1k
David L. Ahmann United States 29 882 0.6× 1.8k 1.6× 637 0.8× 421 0.6× 710 1.6× 70 3.1k
A. Rubagotti Italy 32 1.2k 0.9× 1.6k 1.4× 638 0.8× 479 0.7× 1.3k 3.0× 131 3.7k
M. Namer France 29 1.4k 1.0× 2.4k 2.1× 562 0.7× 302 0.4× 612 1.4× 122 3.7k
Kazuhiro Nouso Japan 39 1.1k 0.8× 1.1k 1.0× 1.3k 1.7× 414 0.6× 206 0.5× 221 5.0k
Gabriel N. Hortobagyi United States 21 583 0.4× 1.3k 1.2× 572 0.7× 196 0.3× 363 0.8× 30 2.3k
G. Di Fronzo Italy 30 1.4k 1.0× 1.7k 1.5× 1.1k 1.4× 838 1.2× 780 1.8× 93 3.3k

Countries citing papers authored by Kapil Dhingra

Since Specialization
Citations

This map shows the geographic impact of Kapil Dhingra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kapil Dhingra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kapil Dhingra more than expected).

Fields of papers citing papers by Kapil Dhingra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kapil Dhingra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kapil Dhingra. The network helps show where Kapil Dhingra may publish in the future.

Co-authorship network of co-authors of Kapil Dhingra

This figure shows the co-authorship network connecting the top 25 collaborators of Kapil Dhingra. A scholar is included among the top collaborators of Kapil Dhingra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kapil Dhingra. Kapil Dhingra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhingra, Kapil, et al.. (2023). Fostering Enhanced Integration Between Early Education and Pediatric Primary Care to Support Whole-Child Health. NEJM Catalyst. 4(5). 1 indexed citations
2.
Dhingra, Kapil, et al.. (2019). Prevalence of Hepatitis B and Hepatitis C Among School Children of Urban and Rural Jaipur, Rajasthan. Journal of Clinical and Experimental Hepatology. 10(3). 272–273. 1 indexed citations
3.
Dhingra, Kapil, et al.. (2010). Tension Pneumothorax in Child with Mild Viral Symptoms. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Dhingra, Kapil, Andrew R. Elms, & Cherri Hobgood. (2010). Reducing Error in the Emergency Department: A Call for Standardization of the Sign-out Process. Annals of Emergency Medicine. 56(6). 637–642. 25 indexed citations
5.
Dhingra, Kapil. (2001). Selective Estrogen Receptor Modulation: The Search for an Ideal Hormonal Therapy for Breast Cancer. Cancer Investigation. 19(6). 649–659. 30 indexed citations
6.
Rivera, Edgardo, Frankie A. Holmes, Vicente Valero, et al.. (2000). Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy. Cancer. 89(11). 2195–2201. 15 indexed citations
7.
Dhingra, Kapil. (1999). Antiestrogens – Tamoxifen, SERMs and Beyond. Investigational New Drugs. 17(3). 285–311. 102 indexed citations
8.
Dhingra, Kapil, Ayşegül A. Şahin, Kamal Emami, Gabriel N. Hortobágyi, & Zeev Estrov. (1998). Expression of leukemia inhibitory factor and its receptor in breast cancer: A potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Research and Treatment. 48(2). 165–174. 38 indexed citations
9.
Singletary, S. Eva, Kapil Dhingra, & Dihua Yu. (1997). New strategies in locally advanced breast cancer. Cancer treatment and research. 90. 253–271. 5 indexed citations
10.
11.
Chen, Taiping, Kapil Dhingra, Ayşegül A. Şahin, et al.. (1996). Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections. Breast Cancer Research and Treatment. 39(2). 177–185. 12 indexed citations
12.
Holmes, Frankie A., et al.. (1996). Paclitaxel: Severe Mucocutaneous Toxicity in a Patient With Hyperbilirubinemia. Southern Medical Journal. 89(5). 542–545. 14 indexed citations
13.
Dhingra, Kapil. (1995). A phase II chemoprevention trial design to identify surrogate surrogate endpoint biomarkers in breast cancer. Journal of Cellular Biochemistry. 59(S23). 19–24. 10 indexed citations
14.
Dhingra, Kapil, Nour Sneige, Tej K. Pandita, et al.. (1994). Quantitative analysis of chromosome in situ hybridization signal in paraffin‐embedded tissue sections. Cytometry. 16(2). 100–112. 31 indexed citations
15.
Pandita, Tej K., V. Grégoire, Kapil Dhingra, & WN Hittelman. (1994). Effect of chromosome size on aberration levels caused by gamma radiation as detected by fluorescence in situ hybridization. Cytogenetic and Genome Research. 67(2). 94–101. 50 indexed citations
16.
Dhingra, Kapil, Daniel J. Booser, Aman U. Buzdar, et al.. (1994). Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study. Advances in experimental medicine and biology. 353. 193–202. 5 indexed citations
17.
Dhingra, Kapil, et al.. (1992). Chromosomein situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications. Breast Cancer Research and Treatment. 23(3). 201–210. 30 indexed citations
18.
Dhingra, Kapil, et al.. (1991). A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum. Investigational New Drugs. 9(1). 37–39. 13 indexed citations
19.
Dhingra, Kapil & Samuel R. Newcom. (1988). Acute tumor lysis syndrome in non‐Hodgkin lymphoma induced by dexamethasone. American Journal of Hematology. 29(2). 115–116. 29 indexed citations
20.
Dhingra, Kapil, et al.. (1988). Transient bone marrow aplasia associated with non‐A, non‐B hepatitis. American Journal of Hematology. 29(3). 168–171. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Bontenbal Breakdown of academic impact, for papers by Vincent Caggiano Breakdown of academic impact, for papers by D C Tormey Breakdown of academic impact, for papers by Kathleen M. Darcy Breakdown of academic impact, for papers by David L. Ahmann Breakdown of academic impact, for papers by A. Rubagotti Breakdown of academic impact, for papers by M. Namer Breakdown of academic impact, for papers by Kazuhiro Nouso Breakdown of academic impact, for papers by Gabriel N. Hortobagyi Breakdown of academic impact, for papers by G. Di Fronzo
Rankless by CCL
2026